FOXP2, APOE, and PRNP: New modulators in primary progressive aphasia

Journal of Alzheimer's Disease

Volumn 28, Issue 4, 2012, Pages 941-950

  Premi, Enrico ^a   Pilotto, Andrea ^a   Alberici, Antonella ^a   Papetti, Alice ^a   Archetti, Silvana ^b   Seripa, Davide ^c   Daniele, Antonio ^d   Masullo, Carlo ^d   Garibotto, Valentina ^e   Paghera, Barbara ^a   Caobelli, Federico ^a   Padovani, Alessandro ^a   Borroni, Barbara ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b Department of Paediatrics   (Italy)

^c CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^d CATHOLIC UNIVERSITY   (Italy)

^e GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Apolipoprotein E 4; FOXP2; primary progressive aphasia; PRNP; progressive non fluent aphasia; semantic dementia; SPECT; statistical parametric mapping

Indexed keywords

APOLIPOPROTEIN E; PRION PROTEIN; TRANSCRIPTION FACTOR FOXP2;

ADULT; AGED; ARTICLE; BRAIN MAPPING; CODON; CONTROLLED STUDY; FEMALE; FRONTAL CORTEX; GENE FREQUENCY; GENETIC RISK; GENETIC VARIABILITY; HOMOZYGOSITY; HUMAN; INFERIOR FRONTAL GYRUS; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; PRIMARY PROGRESSIVE APHASIA; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 84858023007     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2011-111541     Document Type: Article

References (48)

1. Mesulam MM(2001) Primary progressive aphasia. Ann Neurol 49, 425-432.
2. Mesulam MM (2003) Primary progressive aphasia-a language-based dementia. N Engl J Med 349, 1535-1542.
3. Mesulam MM, Grossman M, Hillis A, Kertesz A, Weintraub S (2003) The core and halo of primary progressive aphasia and semantic dementia. Ann Neurol 54(Suppl 5), S11-S14.
4. Mesulam MM (1982) Slowly progressive aphasia without generalized dementia. Ann Neurol 11, 592-598.
5. Gorno-Tempini ML, Dronkers NF, Rankin KP, Ogar JM, Phengrasamy L, Rosen HJ, Johnson JK, Weiner MW, Miller BL (2004) Cognition and anatomy in three variants of primary progressive aphasia. Ann Neurol 55, 335-346.
6. Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, Ogar JM, Rohrer JD, Black S, Boeve BF, Manes F, Dronkers NF, Vandenberghe R, Rascovsky K, Patterson K, Miller BL, Knopman DS, Hodges JR, Mesulam MM, Grossman M (2011) Classification of primary progressive aphasia and its variants. Neurology 76, 1006-1014.
7. Rohrer JD, Ridgway GR, Crutch SJ, Hailstone J, Goll JC, Clarkson MJ, Mead S, Beck J, Mummery C, Ourselin S, Warrington EK, Rossor MN, Warren JD (2010) Progressive logopenic/phonological aphasia: erosion of the language network. Neuroimage 49, 984-993.
8. Hodges JR, Davies RR, Xuereb JH, Casey B, Broe M, Bak TH, Kril JJ, Halliday GM (2004) Clinicopathological correlates in frontotemporal dementia. Ann Neurol 56, 399-406.
9. Josephs KA, Duffy JR, Strand EA, Whitwell JL, Layton KF, Parisi JE, Hauser MF, Witte RJ, Boeve BF, Knopman DS, Dickson DW, Jack CR Jr, Petersen RC (2006) Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech. Brain 129, 1385-1398.
10. Kertesz A, McMonagle P, Blair M, Davidson W, Munoz DG (2005) The evolution and pathology of frontotemporal dementia. Brain 128, 1996-2005.
11. Forman MS, Farmer J, Johnson JK, Clark CM, Arnold SE, Coslett HB, Chatterjee A, Hurtig HI, Karlawish JH, Rosen HJ, Van Deerlin V, Lee VM, Miller BL, Trojanowski JQ, Grossman M (2006) Frontotemporal dementia: Clinicopathological correlations. Ann Neurol 59, 952-962.
12. Mesulam M, Wicklund A, Johnson N, Rogalski E, Leger GC, Rademaker A, Weintraub S, Bigio EH (2008) Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia. Ann Neurol 63, 709-719.
13. Mesulam M, Johnson N, Krefft TA, Gass JM, Cannon AD, Adamson JL, Bigio EH, Weintraub S, Dickson DW, Hutton ML, Graff-Radford NR (2007) Progranulin mutations in primary progressive aphasia: the PPA1 and PPA3 families. Arch Neurol 64, 43-47.
14. Rohrer JD, Warren JD, Barnes J, Mead S, Beck J, Pepple T, Boyes R, Omar R, Collinge J, Stevens JM, Warrington EK, Rossor MN, Fox NC (2008) Mapping the progression of progranulin-associated frontotemporal lobar degeneration. Nat Clin Pract Neurol 4, 455-460.
15. Snowden JS, Pickering-Brown SM, Du PD, Mackenzie IR, Varma A, Mann DM, Neary D (2007) Progressive anomia revisited: focal degeneration associated with progranulin gene mutation. Neurocase 13, 366-377.
16. van Swieten JC, Spillantini MG (2007) Hereditary frontotemporal dementia caused by Tau gene mutations. Brain Pathol 17, 63-73.
17. Newbury DF, Monaco AP (2010) Genetic advances in the study of speech and language disorders. Neuron 68, 309-320.
18. Fisher SE, Scharff C (2009) FOXP2 as a molecular window into speech and language. Trends Genet 25, 166-177.
19. Gopnik M (1990) Genetic basis of grammar defect. Nature 347, 26.
20. Fletcher CM, Prior MR (1990) The rule learning behavior of reading disabled and normal children as a function of task characteristics and instruction. JExp Child Psychol 50, 39-58.
21. Padovani A, Cosseddu M, Premi E, Archetti S, Papetti A, Agosti C, Bigni B, Cerini C, Paghera B, Bellelli G, Borroni B (2010) The speech and language FOXP2 gene modulates the phenotype of frontotemporal lobar degeneration. J Alzheimers Dis 22, 923-931.
22. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261, 921-923.
23. Filippini N, Ebmeier KP, MacIntosh BJ, Trachtenberg AJ, Frisoni GB, Wilcock GK, Beckmann CF, Smith SM, Matthews PM, Mackay CE (2011) Differential effects of the APOE genotype on brain function across the lifespan. Neuroimage 54, 602-610.
24. Seripa D, Bizzarro A, Panza F, Acciarri A, Pellegrini F, Pilotto A, Masullo C (2011) The APOE gene locus in frontotemporal dementia and primary progressive aphasia. Arch Neurol 68, 622-628.
25. Rogalski EJ, Rademaker A, Harrison TM, Helenowski I, Johnson N, Bigio E, Mishra M, Weintraub S, Mesulam MM (2011) ApoE E4 is a susceptibility factor in amnestic but not aphasic dementias. Alzheimer Dis Assoc Disord 25, 159-163.
26. Li X, Rowland LP, Mitsumoto H, Przedborski S, Bird TD, Schellenberg GD, Peskind E, Johnson N, Siddique T, Mesulam MM, Weintraub S, Mastrianni JA (2005) Prion protein codon 129 genotype prevalence is altered in primary progressive aphasia. Ann Neurol 58, 858-864.
27. Rohrer JD, Mead S, Omar R, Poulter M, Warren JD, Collinge J, Rossor MN (2006) Prion protein (PRNP) genotypes in frontotemporal lobar degeneration syndromes. Ann Neurol 60, 616.
28. Wadsworth JD, Asante EA, Desbruslais M, Linehan JM, Joiner S, Gowland I, Welch J, Stone L, Lloyd SE, Hill AF, Brandner S, Collinge J (2004) Human prion protein with valine 129 prevents expression of variant CJD phenotype. Science 306, 1793-1796.
29. Mallik S, Yang W, Norstrom EM, Mastrianni JA (2010) Live cell fluorescence resonance energy transfer predicts an altered molecular association of heterologous PrPSc with PrPC. J Biol Chem 285, 8967-8975.
30. Moreno F, Alzualde A, Camblor PM, Barandiaran M, Van Deerlin VM, Gabilondo A, Masso JF, Lopez de MA, Indakoetxea B (2011) Prion protein codon 129 polymorphism modifies age at onset of frontotemporal dementia with the C.709-1G>A progranulin mutation. Alzheimer Dis Assoc Disord 25, 93-95.
31. Knopman DS, Kramer JH, Boeve BF, Caselli RJ, Graff-Radford NR, Mendez MF, Miller BL, Mercaldo N (2008) Development of methodology for conducting clinical trials in frontotemporal lobar degeneration. Brain 131, 2957-2968.
32. Borroni B, Perani D, Archetti S, Agosti C, Paghera B, Bellelli G, Di LM, Padovani A (2006) Functional correlates of apolipoprotein E genotype in frontotemporal lobar degeneration. BMC Neurol 6, 31.
33. Borroni B, Archetti S, Alberici A, Agosti C, Gennarelli M, Bigni B, Bonvicini C, Ferrari M, Bellelli G, Galimberti D, Scarpini E, Di LD, Caimi L, Caltagirone C, Di LM, Padovani A (2008) Progranulin genetic variations in frontotemporal lobar degeneration: evidence for low mutation frequency in an Italian clinical series. Neurogenetics 9, 197-205.
34. Vargha-Khadem F, Watkins KE, Price CJ, Ashburner J, Alcock KJ, Connelly A, Frackowiak RS, Friston KJ, Pembrey ME, Mishkin M, Gadian DG, Passingham RE (1998) Neural basis of an inherited speech and language disorder. Proc Natl Acad Sci U S A 95, 12695-12700.
35. Fisher SE, Vargha-Khadem F, Watkins KE, Monaco AP, Pembrey ME (1998) Localisation of a gene implicated in a severe speech and language disorder. Nat Genet 18, 168-170.
36. Lai CS, Fisher SE, Hurst JA, Vargha-Khadem F, Monaco AP (2001) A forkhead-domain gene is mutated in a severe speech and language disorder. Nature 413, 519-523.
37. Acciarri A, Masullo C, Bizzarro A, Valenza A, Quaranta D, Marra C, Tiziano FD, Brahe C, Seripa D, Matera MG, Fazio VM, Gainotti G, Daniele A (2006) Apoe epsilon2-epsilon4 genotype is a possible risk factor for primary progressive aphasia. Ann Neurol 59, 436-437.
38. Daniele A, Matera MG, Seripa D, Acciarri A, Bizzarro A, Pilotto A, Masullo C (2009) APOE epsilon 2/epsilon 4 genotype a risk factor for primary progressive aphasia in women. Arch Neurol 66, 910-912.
39. Verghese PB, Castellano JM, Holtzman DM (2011) Apolipoprotein E in Alzheimer's disease and other neurological disorders. Lancet Neurol 10, 241-252.
40. Pickering-Brown SM, Siddons M, Mann DM, Owen F, Neary D, Snowden JS (1995) Apolipoprotein E allelic frequencies in patients with lobar atrophy. Neurosci Lett 188, 205-207.
41. Rosso SM, Roks G, Cruts M, van BC, Heutink P, van Duijn CM, van Swieten JC (2002) Apolipoprotein E4 in the temporal variant of frontotemporal dementia. J Neurol Neurosurg Psychiatry 72, 820.
42. Stevens M, van Duijn CM, de KP, van BC, Heutink P, Oostra BA, Niermeijer MF, van Swieten JC (1997) Apolipoprotein E gene and sporadic frontal lobe dementia. Neurology 48, 1526-1529.
43. Agosta F, Vossel KA, Miller BL, Migliaccio R, Bonasera SJ, Filippi M, Boxer AL, Karydas A, Possin KL, Gorno- Tempini ML (2009) Apolipoprotein E epsilon4 is associated with disease-specific effects on brain atrophy in Alzheimer's disease and frontotemporal dementia. Proc Natl Acad Sci U S A 106, 2018-2022.
44. Boccardi M, Sabattoli F, Testa C, Beltramello A, Soininen H, Frisoni GB (2004) APOE and modulation of Alzheimer's and frontotemporal dementia. Neurosci Lett 356, 167-170.
45. Wishart HA, Saykin AJ, McAllister TW, Rabin LA, McDonald BC, Flashman LA, Roth RM, Mamourian AC, Tsongalis GJ, Rhodes CH (2006) Regional brain atrophy in cognitively intact adults with a single APOE epsilon4 allele. Neurology 67, 1221-1224.
46. Kovacs GG, Seguin J, Quadrio I, Hoftberger R, Kapas I, Streichenberger N, Biacabe AG, Meyronet D, Sciot R, Vandenberghe R, Majtenyi K, Laszlo L, Strobel T, Budka H, Perret-Liaudet A (2011) Genetic Creutzfeldt-Jakob disease associated with the E200K mutation: characterization of a complex proteinopathy. Acta Neuropathol 121, 39-57.
47. Zhou J, Greicius MD, Gennatas ED, Growdon ME, Jang JY, Rabinovici GD, Kramer JH, Weiner M, Miller BL, Seeley WW (2010) Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer's disease. Brain 133, 1352-1367.
48. Kim EJ, Sidhu M, Gaus SE, Huang EJ, Hof PR, Miller BL, Dearmond SJ, Seeley WW (2011) Selective Frontoinsular von Economo neuron and fork cell loss in early behavioral variant frontotemporal dementia. Cereb Cortex, doi: 10.1093/cercor/bhr004.